Pulmonary Delivery of Butyrylcholinesterase as a Model Protein to the Lung-Reference-Cited by-同舟云学术

Pulmonary Delivery of Butyrylcholinesterase as a Model Protein to the Lung

Published:2016-04-05 Issue:5 Volume:13 Page:1626-1635
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Rahhal Tojan B.¹,Fromen Catherine A.²,Wilson Erin M.¹,Kai Marc P.²,Shen Tammy W.¹,Luft J. Christopher¹,DeSimone Joseph M.¹²³⁴

Affiliation:

1. Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

2. Department of Chemical & Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695, United States

3. Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

National Cancer Institute

Division of Graduate Education

Defense Threat Reduction Agency

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.6b00066

Reference49 articles.

1. Protein stability in pulmonary drug delivery via nebulization

2. Targeted delivery of nanoparticles for the treatment of lung diseases

3. Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis

4. Delivery of Antioxidant Enzyme Proteins to the Lung

5. The Particle has Landed—Characterizing the Fate of Inhaled Pharmaceuticals

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aerosol pulmonary immune engineering;Advanced Drug Delivery Reviews;2023-08

2. Emerging trends in pulmonary delivery of biopharmaceuticals;Drug Discovery Today;2022-05

3. Protein and peptide delivery to lungs by using advanced targeted drug delivery;Chemico-Biological Interactions;2022-01

4. Biologics and Vaccines for Nasal and Pulmonary Drug Delivery;Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases;2022

5. Comparative analysis of pharmacokinetics of vancomycin hydrochloride in rabbits after ocular, intragastric, and intravenous administration by LC-MS/MS;Xenobiotica;2020-06-04